Summary
- Current Price
- As of today, DYN price is $18.06, up +4.36% on
- Current Price All-Time High
- DYN price is currently -61.94% below its historical high of $47.45 set on
- Market Cap
- DYN current market cap is $3B, up +124.31% over the past 365 days
- Revenue
- DYN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DYN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Dyne Therapeutics, Inc. |
| Ticker | NASDAQ: DYN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | dyne-tx.com |
| Employees | 206 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $18.06 | |
| Price, 1D Change | +4.36% | |
| $3B | ||
| - | ||
| - | ||
| 2.09 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.47 | ||
| EPS, 1Y Change | -3.04% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.47 | ||
| EPS Estimate | -$3.55 | N/A |
| EPS Est. Change | -2.16% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $18.06 | |
| Price Target | $37.00 | - |
| Price Tgt. Change | +104.87% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.45 | -$3.37 | +2.28% | |
| -$3.53 | -$3.47 | +1.61% | |
| -$3.55 | N/A | -2.16% | |
| -$3.33 | N/A | +4.06% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $52.79M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $18.06 | |
| $19.82 | ||
| $24.12 | ||
| $20.36 | ||
| $22.73 | ||
| -$2.01 | ||
| 2.09 | ||
| $1.27 | ||
| 25.09 | ||
| 87.03% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.47 | ||
| -$2.05M | ||
| - | ||
| -$468.18M | ||
| - | ||
| -$446.21M | ||
| - | ||
| -$466.14M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.17 | ||
| 22.25 | ||
| 22.25 | ||
| - | ||
| - | ||
| 7.56 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.80 | ||
| -5.06 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $972.13M | ||
| $1.11B | ||
| $1.19B | ||
| $1.13B | ||
| $214.83M | ||
| $50.63M | ||
| $169.20M | ||
| $5.00M | ||
| $8.08M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $446.21M | ||
| $466.14M | ||
| $2.05M | ||
| $0.00 | ||
| $2.05M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$403.21M | ||
| -$28.75M | ||
| $890.31M | ||
| $20.71M | ||
| -$423.92M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| RBC Capital | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| Baird | → | |
| Morgan Stanley | → | |
| RBC Capital | → | |
| Cantor Fitzgerald | ||
| TD Cowen | ||
| Evercore ISI Group | → | |
| Bernstein | → |
Analyst sentiment
Institutional ownership
No data
Screeners with DYN
FAQ
- What is the ticker symbol for Dyne Therapeutics, Inc.?
- The ticker symbol for Dyne Therapeutics, Inc. is NASDAQ:DYN
- Does Dyne Therapeutics, Inc. pay dividends?
- No, Dyne Therapeutics, Inc. does not pay dividends
- What sector is Dyne Therapeutics, Inc. in?
- Dyne Therapeutics, Inc. is in the Healthcare sector
- What industry is Dyne Therapeutics, Inc. in?
- Dyne Therapeutics, Inc. is in the Biotechnology industry
- What country is Dyne Therapeutics, Inc. based in?
- Dyne Therapeutics, Inc. is headquartered in United States
- When did Dyne Therapeutics, Inc. go public?
- Dyne Therapeutics, Inc. initial public offering (IPO) was on September 17, 2020
- Is Dyne Therapeutics, Inc. in the S&P 500?
- No, Dyne Therapeutics, Inc. is not included in the S&P 500 index
- Is Dyne Therapeutics, Inc. in the NASDAQ 100?
- No, Dyne Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Dyne Therapeutics, Inc. in the Dow Jones?
- No, Dyne Therapeutics, Inc. is not included in the Dow Jones index
- When was Dyne Therapeutics, Inc. last earnings report?
- Dyne Therapeutics, Inc.'s most recent earnings report was on July 29, 2026
- When does Dyne Therapeutics, Inc. report earnings?
- The next expected earnings date for Dyne Therapeutics, Inc. is November 5, 2026
Data Sources & References
- DYN Official Website www.dyne-tx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1818794/000119312526084178/0001193125-26-084178-index.htm
- DYN Profile on Yahoo Finance finance.yahoo.com/quote/DYN
- DYN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dyn